RBC Capital Initiates Coverage On Korro Bio with Outperform Rating, Announces Price Target of $70
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Luca Issi has initiated coverage on Korro Bio (NASDAQ:KRRO) with an Outperform rating and set a price target of $70.

November 29, 2023 | 11:03 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Korro Bio has been initiated with an Outperform rating by RBC Capital, which could attract investor interest and potentially drive the stock price up towards the $70 price target.
Analyst coverage, especially with an Outperform rating, often leads to increased investor confidence and can result in a positive short term price movement. The $70 price target suggests significant upside potential from the current trading price, assuming the market aligns with the analyst's outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100